北京大学学报(医学版) ›› 2018, Vol. 50 ›› Issue (6): 1098-1101. doi: 10.19723/j.issn.1671-167X.2018.06.028

• 疑难/罕见病例分析 • 上一篇    下一篇

盆腹腔软组织侵袭性血管黏液瘤临床病理分析

刘蕾(),王丽华,任玉波,饶晓松,杨邵敏   

  1. 北京大学国际医院病理科, 北京 102206
  • 收稿日期:2017-07-04 出版日期:2018-12-18 发布日期:2018-12-18
  • 通讯作者: 刘蕾 E-mail:leids_l@hotmail.com

Clinicopathological analysis of aggressive angiomyxoma of soft tissue in abdomino-pelvic cavity

Lei LIU(),Li-hua WANG,Yu-bo REN,Xiao-song RAO,Shao-min YANG   

  1. Department of Pathology, Peking University International Hospital, Beijing 102206, China
  • Received:2017-07-04 Online:2018-12-18 Published:2018-12-18
  • Contact: Lei LIU E-mail:leids_l@hotmail.com

RICH HTML

20   

摘要:

侵袭性血管黏液瘤是一种少见的间叶性肿瘤,为探讨其临床病理学特征、诊治及预后,本研究收集北京大学国际医院4例盆腹腔软组织侵袭性血管黏液瘤的临床影像资料,分析其病理学形态、免疫表型及治疗随访情况,并回顾相关文献。本组4例均为女性,年龄27~49岁,平均年龄33岁,无诱因腹胀或无明显不适经体检发现,3例原发、1例复发。3例CT及磁共振扫描可见分层/漩涡征。肿瘤主体均位于盆腔,1例同时累及腹腔。肿瘤最大径5~22 cm,切面灰白、灰黄色,实性,质软,灶性水肿或囊性改变。显微镜下瘤细胞短梭形,异型不明显,间质富疏松水肿黏液或胶原,有丰富的薄壁及厚壁血管,部分血管壁玻璃样变性。肿瘤可浸润周围脂肪、神经组织。免疫组织化学染色提示4例肿瘤均雌激素受体、孕激素受体、结蛋白、平滑肌肌动蛋白弥漫阳性,CD34仅血管表达,S-100蛋白、CD117、Dog1均阴性。手术完整切除肿瘤,术后随访有1例二次复发。侵袭性血管黏液瘤确诊以病理形态学为基础,辅以免疫组织化学进一步诊断及鉴别诊断;手术切除后可多次复发。

关键词: 黏液瘤, 盆腔肿瘤, 病理学, 临床, 免疫组织化学

Abstract:

Aggressive angiomyxoma is a rare mesenchymal tumor. To discuss the clinicopathological characteristics, treatment and prognosis of aggressive angiomyxoma, four cases of aggressive angiomyxoma of soft tissue in abdominopelvic cavity were collected from January 2015 to August 2017 in Peking University International Hospital. The clinical data, imaging examination, histopathological features, immunophenotype, therapy and prognosis were analysed. The related literatures were reviewed. All of the patients were adult females, age range from 27 to 49 years and mean 33 years. The clinical complaint was abdominal distention with no definite predisposing factor, or occasional physical-exam finding with no obvious discomfort. Three cases were primary and one case was recurrent. Typical layered or swirled structural sign was presented by CT and MRI scanning of three cases. All tumors located in the pelvic cavity, and attached to the uterus, vagina, rectum, bladder or ureter. One case was involved in the abdominal cavity simultaneously,adhesive to the spine, inferior vena cava and spleen. The gross appearance of tumors was from 5 to 22 cm in maximum diameter. The sectioned surfaces were soft, solid, white or yellow-gray, focally accompanied by edema, mucoid degeneration or cystic change. Microscopic observation showed that tumor cells were short spindle shaped and little atypical, the stroma was loose like ede-matous mucus or collagen, and the vessels were rich in thin and thick-wall. Partially the vessel wall expressed hyaline degeneration. Also tumors might infiltrate surrounding tissue, such as fat or nerve. The immunohistochemistry results of all cases were estrogen receptor and progesterone receptor diffusely mo-derate positive, Desmin and smooth muscle actin mostly positive, whereas CD34 expressed only in vessel and S-100 protein, CD117 and Dog1 all negative. All the tumors were complete surgical excision. During follow-up, one case recurred the second time. Our conclusions are the diagnosis of aggressive angiomy-xoma is based on pathological morphology supplemented by immunohistochemistry, and the tumor may relapse after surgical resection.

Key words: Myxoma, Pelvic neoplasms, Pathology, clinical, Immunohistochemistry

中图分类号: 

  • R739.9

图1

肿瘤切面水肿、黏液样变性"

图2

肿瘤细胞短梭形、稀疏,间质富黏液样基质,血管壁玻璃样变性(HE ×40)"

图3

肿瘤富含薄壁和厚壁血管,网织纤维染色(A, 银染法 ×40)和免疫组织化学染色CD34阳性(B,EnVision ×40)"

图4

肿瘤细胞免疫组织化学染色(EnVision ×100):A,ER弥漫核阳性;B,PR弥漫核阳性;C,SMA胞浆阳性"

[1] Fletcher CDM, Bridge JA, Hogendoorn PCW , et al. World Health Organization classification of tumours of soft tissue and bone [M]. Lyon: IARC Press, 2013.
[2] Zhang JP, Zhu CF . Clinical experiences on aggressive angio-myxoma in China (report of 93 cases)[J]. Int J Gynecol Cancer, 2010,20(2):303-307.
doi: 10.1111/IGC.0b013e3181cc339c pmid: 20134274
[3] Ahmed MA, Uehelie MA, Rage AM , et al. Aggressive angio-myxoma of the penis: the first case report in a 9-month-old infant[J]. Urology, 2017,104(6):187-190.
doi: 10.1016/j.urology.2016.12.045
[4] Surabhi VR, Garg N, Frumovitz M , et al. Aggressive angio-myxomas: a comprehensive imaging review with clinical and histopathologic correlation[J]. Am J Roentgenol, 2014,202(6):1171-1178.
doi: 10.2214/AJR.13.11668 pmid: 24848813
[5] Petscavage-Thomas JM, Walker EA, Logie CI , et al. Soft-tissue myxomatous lesions: review of salient imaging features with pathologic comparison[J]. Radiographics, 2014,34(4):964-980.
doi: 10.1148/rg.344130110 pmid: 25019435
[6] Sun Y, Zhu L, Chang X , et al. Clinicopathological features and treatment analysis of rare aggressive angiomyxoma of the female pelvis and perineum: a retrospective study[J]. Pathol Oncol Res, 2017,23(1):131-137.
doi: 10.1007/s12253-016-0109-y pmid: 27571990
[7] Chen H, Zhao H, Xie Y , et al. Clinicopathological features and differential diagnosis of aggressive angiomyxoma of the female pelvis: 5 case reports and literature review[J]. Medicine (Baltimore), 2017,96(20):e6820.
doi: 10.1097/MD.0000000000006820
[8] 魏红权, 刘珺, 冯晶晶 . 侵袭性血管黏液瘤临床病理观察[J]. 中华医学杂志, 2012,92(22):1553-1555.
doi: 10.3760/cma.j.issn.0376-2491.2012.22.013
[9] Alameda F, Munne A, Baro T , et al. Vulvar angiomyxoma, aggressive angiomyxoma, and angiomyofibroblastoma: an immunohistochemical and ultrastructural study[J]. Ultrastruct Pathol, 2006,30(3):193-205.
doi: 10.1080/01913120500520911 pmid: 16825121
[10] Rawlinson NJ, West WW, Nelson M , et al. Aggressive angio-myxoma with t(12;21) and HMGA2 rearrangement: report of a case and review of the literature[J]. Cancer Genet Cytogenet, 2008,181(2):119-124.
doi: 10.1016/j.cancergencyto.2007.11.008 pmid: 18295664
[11] Jiang XX, Qian LH, Xu HK , et al. Mutation of an X chromosome in aggressive angiomyxoma: Report of a case and review of the literature[J]. Gynecol Oncol Case Rep, 2011,2(2):39-41.
doi: 10.1016/j.gynor.2011.12.001 pmid: 3860615
[12] Bai HM, Yang JX, Huang HF , et al. Individualized managing strategies of aggressive angiomyxoma of female genital tract and pelvis[J]. Eur J Surg Oncol, 2013,39(10):1101-1108.
doi: 10.1016/j.ejso.2013.06.013 pmid: 23899874
[13] Han-Geurts IJ, van Geel AN, van Doorn L , et al. Aggressive angiomyxoma: multimodality treatments can avoid mutilating surgery[J]. Eur J Surg Oncol, 2006,32(10):1217-1221.
doi: 10.1016/j.ejso.2006.06.008 pmid: 16870390
[14] Orfanelli T, Kim CS, Vitez SF , et al. A case report of aggressive angiomyxoma in pregnancy: do hormones play a role[J]. Case Rep Obstet Gynecol, 2016(3):1-4.
doi: 10.1155/2016/6810368
[15] 宫丽华, 孙晓淇, 孟淑琴 , 等. 骨内侵袭性血管黏液瘤的诊断及与其他黏液性骨肿瘤的鉴别[J]. 临床与实验病理学杂志, 2012,28(10):1143-1145.
doi: 10.3969/j.issn.1001-7399.2012.10.019
[16] Schwartz PE, Hui P , McCarthy S. Hormonal therapy for aggressive angiomyxoma: a case report and proposed management algorithm[J]. J Low Genit Tract Dis, 2014,18(2):55-61.
doi: 10.1097/LGT.0b013e3182a22019
[17] Wang Z, Liu Y, Yang L , et al. Maxillary aggressive angiomyxoma showing ineffective to radiotherapy: a rare case report and review of literature[J]. Int J Clin Exp Pathol, 2015,8(1):1063-1067.
pmid: 25755820
[18] Coppola S, Desai A, Tzanis D , et al. Conservative en bloc surgery for aggressive angiomyxoma achieves good local control: analysis of 14 patients from a single institution[J]. Int J Gynecol Cancer, 2013,23(3):540-545.
doi: 10.1097/IGC.0b013e3182843063
[19] Blandamura S, Cruz J, Faure Vergara L , et al. Aggressive angiomyxoma: a second case of metastasis with patient’s death[J]. Hum Pathol, 2003,34(10):1072-1074.
doi: 10.1053/S0046-8177(03)00419-2 pmid: 14608546
[20] Geng J, Cao B, Wang L . Aggressive angiomyxoma: an unusual presentation[J]. Korean J Radiol, 2012,13(1):90-93.
doi: 10.3348/kjr.2012.13.1.90 pmid: 22247641
[1] 邢念增,王明帅,杨飞亚,尹路,韩苏军. 前列腺免活检创新理念的临床实践及其应用前景[J]. 北京大学学报(医学版), 2024, 56(4): 565-566.
[2] 田宇轩,阮明健,刘毅,李德润,吴静云,沈棋,范宇,金杰. 双参数MRI改良PI-RADS评分4分和5分病灶的最大径对临床有意义前列腺癌的预测效果[J]. 北京大学学报(医学版), 2024, 56(4): 567-574.
[3] 刘帅,刘磊,刘茁,张帆,马潞林,田晓军,侯小飞,王国良,赵磊,张树栋. 伴静脉癌栓的肾上腺皮质癌的临床治疗及预后[J]. 北京大学学报(医学版), 2024, 56(4): 624-630.
[4] 赖展鸿,李嘉辰,贠泽霖,张永刚,张昊,邢晓燕,邵苗,金月波,王乃迪,李依敏,李玉慧,栗占国. 特发性炎性肌病完全临床应答相关因素的单中心真实世界研究[J]. 北京大学学报(医学版), 2024, 56(2): 284-292.
[5] 徐训敏,邵校,姬爱平. 口腔急诊科死亡病例分析[J]. 北京大学学报(医学版), 2024, 56(1): 185-189.
[6] 冯璐,翟佳羽,赵金霞. IgG4相关性疾病患者就诊情况及其临床特征[J]. 北京大学学报(医学版), 2023, 55(6): 1028-1032.
[7] 薛子璇,唐世英,邱敏,刘承,田晓军,陆敏,董靖晗,马潞林,张树栋. 青年肾肿瘤伴瘤栓的临床病理特征及预后分析[J]. 北京大学学报(医学版), 2023, 55(5): 802-811.
[8] 魏慧,次旦央宗,益西拉姆,白玛央金. 高原地区不同类型过敏性紫癜藏族患者发病的相关危险因素[J]. 北京大学学报(医学版), 2023, 55(5): 923-928.
[9] 时云飞,王豪杰,刘卫平,米岚,龙孟平,刘雁飞,赖玉梅,周立新,刁新婷,李向红. 血管免疫母细胞性T细胞淋巴瘤临床与分子病理学特征分析[J]. 北京大学学报(医学版), 2023, 55(3): 521-529.
[10] 马利加,胡攀攀,刘晓光. 脊柱转移癌伴软脊膜转移1例[J]. 北京大学学报(医学版), 2023, 55(3): 563-566.
[11] 李挺. 建设当代临床病理学科[J]. 北京大学学报(医学版), 2023, 55(2): 197-200.
[12] 周桥. 肿瘤病理学研究的进展和展望[J]. 北京大学学报(医学版), 2023, 55(2): 201-209.
[13] 朱晓娟,张虹,张爽,李东,李鑫,徐玲,李挺. 人表皮生长因子受体2低表达乳腺癌的临床病理学特征及预后[J]. 北京大学学报(医学版), 2023, 55(2): 243-253.
[14] 赖玉梅,李忠武,李欢,吴艳,时云飞,周立新,楼雨彤,崔传亮. 68例肛管直肠黏膜黑色素瘤临床病理特征及预后[J]. 北京大学学报(医学版), 2023, 55(2): 262-269.
[15] 沈棋,刘亿骁,何群. 肾黏液样小管状和梭形细胞癌的临床病理特点及预后[J]. 北京大学学报(医学版), 2023, 55(2): 276-282.
Viewed
Full text
407
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 20 0 0 387

  From Others local
  Times 51 356
  Rate 13% 87%

Abstract
1251
Just accepted Online first Issue
0 0 1251
  From Others local
  Times 1246 5
  Rate 100% 0%

Cited

Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
No Suggested Reading articles found!